Emily Fisher

Point-of-care Medical Sensor Adoption Driven by Cancer, Infectious Diseases

Innovation will be important, but regulators and insurers will play vital roles in driving use of diagnostics and monitoring outside hospitals, Lux Research says


BOSTON, MA – May 5, 2015 – Sensor-based point-of-care medical devices that can be used outside hospitals will first make an impact in cancer care and infectious diseases as rapid innovation, coupled with regulatory and insurer enthusiasm, drives adoption, according to Lux Research.

Three major sensing technologies – imaging, optical molecular and electrochemical – will be ready for strong adoption in oncology by 2030, while the more challenging infectious diseases will see similar adoption but mainly of electrochemical sensors.

“Decisions on which sensors to develop depend heavily on market dynamics and requirements, as needs differ from one indication space to another,” said Milos Todorovic, Lux Research Analyst and lead author of the report titled, “Sensing (Is) the Future of Health Care: Technology Roadmapping Helps Find the Way.”

“The time to get into point-of-care medical diagnostics is now, given the long product development cycles in the highly regulated medical devices industry, because today’s decisions will impact market performance beyond 2020,” he added.

Lux Research analysts evaluated key point-of-care sensing technology families to predict likely adoption curves in key clinical indication spaces. Among their findings:

  • Imaging systems will dominate cancer care technology. Over the next decade, optical coherence tomography (OCT) will emerge as the dominant imaging technology in cancer care as novel imaging modalities start disrupting large legacy systems such as MRI, CT and PET.
  • Challenges abound in infectious diseases. Infectious diseases pose a big challenge for medical sensors, mainly on account of the sheer number of pathogens. Most approaches focus on in-vitro diagnostics (IVD), with electrochemical sensors seeing the largest adoption due to high stability.
  • Neurology has long-term potential. Sensors for neurology are less mature than those for infectious diseases and cancer, but potentially represent the largest opportunity in the long run due to demographic and epidemiological trends. Electrodes and imaging will lead the pack for neurological uses.

The report, titled “Sensing (Is) the Future of Health Care: Technology Roadmapping Helps Find the Way,” is part of the Lux Research BioElectronics Intelligence service.

Tuesday, May 5, 2015

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory services, helping clients drive growth through technology innovation. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make better, informed decisions today to ensure future success. A pioneer in the research industry, Lux is uniquely positioned with technical expertise in addition to business insights, augmented by advanced analytics and data science.

Analysis you trust. Opinions you rely on. Make better decisions, faster. For more information visit, connect on LinkedIn, or follow @LuxResearch.